Ovid Therapeutics
OVID
OVID
42 hedge funds and large institutions have $61.5M invested in Ovid Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$534K | |
| 2 | +$403K | |
| 3 | +$191K | |
| 4 |
Jennison Associates
New York
|
+$153K |
| 5 |
CI
Cowen Inc
New York
|
+$88K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$1.42M | |
| 3 | -$923K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$503K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$328K |